夏威夷法院命令百时美施贵宝和赛诺菲的美国子公司支付 9.16 亿美元，因为未能披露血液稀释剂波立维的功效和安全性。 Hawaii court orders Bristol Myers Squibb & Sanofi's US subsidiaries to pay $916m for failing to disclose efficacy and safety of blood thinner Plavix.

夏威夷法院命令百时美施贵宝和赛诺菲的美国子公司支付 9.16 亿美元，因为未能披露血液稀释剂波立维的功效和安全性。 Hawaii court orders Bristol Myers Squibb & Sanofi's US subsidiaries to pay $916m for failing to disclose efficacy and safety of blood thinner Plavix. 第一巡回法院法官詹姆斯·阿什福德 (James Ashford) 发现，尽管公司知道大约 30% 的患者（特别是非白种人）对该药的反应减弱，但公司并未更新波立维的标签。 First Circuit Court Judge James Ashford found companies didn't update Plavix label despite knowing about 30% patients, particularly non-Caucasians, having a diminished response to the drug. 制药巨头对该判决提出异议并计划上诉。 The pharmaceutical giants dispute the judgement and plan to appeal.